vs
MP Materials Corp.（MP）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
MP Materials Corp.的季度营收约是ARS Pharmaceuticals, Inc.的1.9倍（$52.7M vs $28.1M），MP Materials Corp.净利率更高（17.9% vs -147.1%，领先165.0%），MP Materials Corp.同比增速更快（-13.6% vs -67.6%）
MP Materials Corp.是总部位于美国的稀土材料生产商，拥有并运营加利福尼亚州芒廷帕斯矿，这是西半球唯一在产的稀土开采及加工设施，所产核心材料可广泛应用于电动汽车、风力发电机、国防工业等多个关键领域。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
MP vs SPRY — 直观对比
营收规模更大
MP
是对方的1.9倍
$28.1M
营收增速更快
MP
高出53.9%
-67.6%
净利率更高
MP
高出165.0%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $28.1M |
| 净利润 | $9.4M | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | -7.0% | -147.6% |
| 净利率 | 17.9% | -147.1% |
| 营收同比 | -13.6% | -67.6% |
| 净利润同比 | 142.2% | -182.8% |
| 每股收益（稀释后） | $0.07 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPSPRY
| Q4 25 | $52.7M | $28.1M | ||
| Q3 25 | $53.6M | $32.5M | ||
| Q2 25 | $57.4M | $15.7M | ||
| Q1 25 | $60.8M | $8.0M | ||
| Q4 24 | $61.0M | $86.6M | ||
| Q3 24 | $62.9M | $2.1M | ||
| Q2 24 | $31.3M | $500.0K | ||
| Q1 24 | $48.7M | $0 |
净利润MPSPRY
| Q4 25 | $9.4M | $-41.3M | ||
| Q3 25 | $-41.8M | $-51.2M | ||
| Q2 25 | $-30.9M | $-44.9M | ||
| Q1 25 | $-22.6M | $-33.9M | ||
| Q4 24 | $-22.3M | $49.9M | ||
| Q3 24 | $-25.5M | $-19.1M | ||
| Q2 24 | $-34.1M | $-12.5M | ||
| Q1 24 | $16.5M | $-10.3M |
营业利润率MPSPRY
| Q4 25 | -7.0% | -147.6% | ||
| Q3 25 | -125.2% | -163.7% | ||
| Q2 25 | -76.5% | -302.9% | ||
| Q1 25 | -57.2% | -466.3% | ||
| Q4 24 | -72.1% | 54.5% | ||
| Q3 24 | -62.8% | -1051.6% | ||
| Q2 24 | -171.1% | -3068.0% | ||
| Q1 24 | -66.6% | — |
净利率MPSPRY
| Q4 25 | 17.9% | -147.1% | ||
| Q3 25 | -78.0% | -157.4% | ||
| Q2 25 | -53.8% | -285.6% | ||
| Q1 25 | -37.2% | -425.7% | ||
| Q4 24 | -36.6% | 57.7% | ||
| Q3 24 | -40.5% | -925.0% | ||
| Q2 24 | -108.9% | -2503.2% | ||
| Q1 24 | 33.9% | — |
每股收益（稀释后）MPSPRY
| Q4 25 | $0.07 | $-0.41 | ||
| Q3 25 | $-0.24 | $-0.52 | ||
| Q2 25 | $-0.19 | $-0.46 | ||
| Q1 25 | $-0.14 | $-0.35 | ||
| Q4 24 | $-0.12 | $0.52 | ||
| Q3 24 | $-0.16 | $-0.20 | ||
| Q2 24 | $-0.21 | $-0.13 | ||
| Q1 24 | $-0.08 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $245.0M |
| 总债务越低越好 | $998.7M | $96.4M |
| 股东权益账面价值 | $2.0B | $114.3M |
| 总资产 | $3.9B | $327.7M |
| 负债/权益比越低杠杆越低 | 0.50× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资MPSPRY
| Q4 25 | $1.2B | $245.0M | ||
| Q3 25 | $1.1B | $288.2M | ||
| Q2 25 | $261.5M | $240.1M | ||
| Q1 25 | $198.3M | $275.7M | ||
| Q4 24 | $282.4M | $314.0M | ||
| Q3 24 | $284.4M | $204.6M | ||
| Q2 24 | $295.6M | $218.7M | ||
| Q1 24 | $296.5M | $223.6M |
总债务MPSPRY
| Q4 25 | $998.7M | $96.4M | ||
| Q3 25 | $997.3M | $96.2M | ||
| Q2 25 | $910.8M | — | ||
| Q1 25 | $909.8M | — | ||
| Q4 24 | $908.7M | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MPSPRY
| Q4 25 | $2.0B | $114.3M | ||
| Q3 25 | $2.0B | $147.7M | ||
| Q2 25 | $1.0B | $192.3M | ||
| Q1 25 | $1.0B | $229.0M | ||
| Q4 24 | $1.1B | $256.8M | ||
| Q3 24 | $1.1B | $201.0M | ||
| Q2 24 | $1.1B | $215.2M | ||
| Q1 24 | $1.1B | $223.9M |
总资产MPSPRY
| Q4 25 | $3.9B | $327.7M | ||
| Q3 25 | $3.8B | $372.8M | ||
| Q2 25 | $2.3B | $313.5M | ||
| Q1 25 | $2.4B | $327.3M | ||
| Q4 24 | $2.3B | $351.2M | ||
| Q3 24 | $2.3B | $217.6M | ||
| Q2 24 | $2.4B | $222.0M | ||
| Q1 24 | $2.4B | $227.6M |
负债/权益比MPSPRY
| Q4 25 | 0.50× | 0.84× | ||
| Q3 25 | 0.51× | 0.65× | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.88× | — | ||
| Q4 24 | 0.86× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-46.9M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $-109.3M | — |
| 自由现金流率自由现金流/营收 | -207.4% | — |
| 资本支出强度资本支出/营收 | 118.5% | 0.0% |
| 现金转化率经营现金流/净利润 | -4.97× | — |
| 过去12个月自由现金流最近4个季度 | $-328.1M | — |
8季度趋势，按日历期对齐
经营现金流MPSPRY
| Q4 25 | $-46.9M | $-43.5M | ||
| Q3 25 | $-42.0M | $-47.0M | ||
| Q2 25 | $-3.7M | $-39.6M | ||
| Q1 25 | $-63.2M | $-40.7M | ||
| Q4 24 | $30.5M | $42.0M | ||
| Q3 24 | $-6.8M | $-14.5M | ||
| Q2 24 | $30.8M | $-7.3M | ||
| Q1 24 | $-41.1M | $-6.7M |
自由现金流MPSPRY
| Q4 25 | $-109.3M | — | ||
| Q3 25 | $-92.5M | $-47.2M | ||
| Q2 25 | $-32.7M | $-39.6M | ||
| Q1 25 | $-93.7M | $-40.8M | ||
| Q4 24 | $-11.2M | $41.7M | ||
| Q3 24 | $-53.3M | $-14.6M | ||
| Q2 24 | $-15.6M | $-7.3M | ||
| Q1 24 | $-93.0M | $-6.8M |
自由现金流率MPSPRY
| Q4 25 | -207.4% | — | ||
| Q3 25 | -172.8% | -145.4% | ||
| Q2 25 | -56.9% | -252.2% | ||
| Q1 25 | -154.0% | -512.1% | ||
| Q4 24 | -18.3% | 48.2% | ||
| Q3 24 | -84.7% | -706.3% | ||
| Q2 24 | -50.1% | -1463.4% | ||
| Q1 24 | -191.0% | — |
资本支出强度MPSPRY
| Q4 25 | 118.5% | 0.0% | ||
| Q3 25 | 94.3% | 0.6% | ||
| Q2 25 | 50.5% | 0.3% | ||
| Q1 25 | 50.1% | 1.1% | ||
| Q4 24 | 68.3% | 0.3% | ||
| Q3 24 | 73.8% | 6.8% | ||
| Q2 24 | 148.7% | 7.6% | ||
| Q1 24 | 106.5% | — |
现金转化率MPSPRY
| Q4 25 | -4.97× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MP
| Materials Segment | $35.6M | 68% |
| Other | $17.1M | 32% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
